Lipella Pharmaceuticals Common Price Prediction
| LIPODelisted Stock | 1.65 0.11 6.25% |
Momentum 58
Buy Extended
Oversold | Overbought |
Using Lipella Pharmaceuticals hype-based prediction, you can estimate the value of Lipella Pharmaceuticals Common from the perspective of Lipella Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Lipella Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Lipella because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Lipella Pharmaceuticals after-hype prediction price | USD 1.78 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Lipella |
Lipella Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Lipella Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lipella Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Lipella Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Lipella Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Lipella Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lipella Pharmaceuticals' historical news coverage. Lipella Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.09 and 10.39, respectively. We have considered Lipella Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Lipella Pharmaceuticals is extremely dangerous at this time. Analysis and calculation of next after-hype price of Lipella Pharmaceuticals is based on 3 months time horizon.
Lipella Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Lipella Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lipella Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lipella Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.45 | 8.61 | 0.13 | 0.05 | 6 Events / Month | 2 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.65 | 1.78 | 7.88 |
|
Lipella Pharmaceuticals Hype Timeline
Lipella Pharmaceuticals is now traded for 1.65. The entity has historical hype elasticity of 0.13, and average elasticity to hype of competition of -0.05. Lipella is projected to increase in value after the next headline, with the price projected to jump to 1.78 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 7.88%, whereas the daily expected return is now at -1.45%. The volatility of related hype on Lipella Pharmaceuticals is about 25830.0%, with the expected price after the next announcement by competition of 1.60. Given the investment horizon of 90 days the next projected press release will be in about 6 days. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.Lipella Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Lipella Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Lipella Pharmaceuticals' future price movements. Getting to know how Lipella Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lipella Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PCSA | Processa Pharmaceuticals | 0.00 | 10 per month | 7.03 | 0.02 | 13.64 | (12.50) | 50.00 | |
| ACXP | Acurx Pharmaceuticals LLC | 0.09 | 13 per month | 6.60 | 0.02 | 9.64 | (12.47) | 191.04 | |
| FENC | Fennec Pharmaceuticals | (0.16) | 10 per month | 2.26 | 0.13 | 6.71 | (4.16) | 17.35 | |
| PXMD | PaxMedica, Common Stock | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SANG | Sangoma Technologies Corp | (0.14) | 6 per month | 2.09 | (0.01) | 4.94 | (4.01) | 10.90 | |
| XPON | Expion360 | 0.01 | 7 per month | 5.59 | 0.13 | 14.29 | (9.72) | 64.33 |
Lipella Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Lipella price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lipella using various technical indicators. When you analyze Lipella charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Lipella Pharmaceuticals Predictive Indicators
The successful prediction of Lipella Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lipella Pharmaceuticals Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lipella Pharmaceuticals based on analysis of Lipella Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lipella Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lipella Pharmaceuticals's related companies.
Story Coverage note for Lipella Pharmaceuticals
The number of cover stories for Lipella Pharmaceuticals depends on current market conditions and Lipella Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lipella Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lipella Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Lipella Pharmaceuticals Short Properties
Lipella Pharmaceuticals' future price predictability will typically decrease when Lipella Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lipella Pharmaceuticals Common often depends not only on the future outlook of the potential Lipella Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lipella Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1 M | |
| Cash And Short Term Investments | 2.2 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Lipella Stock
If you are still planning to invest in Lipella Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lipella Pharmaceuticals' history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |